Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reika Maezawa

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Rheumatic Diseases|November 1, 2023
Subclinical myositis in antisynthetase syndrome-Does it matter?Kei Ikeda, Reika Maezawa, Kazuhiro Kurasawa
The Journal of Rheumatology|February 13, 2013
Dr. Owada, et al, replyTakayoshi Owada, Reika Maezawa, Kazuhiro Kurasawa
Modern Rheumatology|June 28, 2011
Systemic sclerosis complicated by arrhythmogenic right ventricular dysplasia that was misinterpreted as pulmonary arterial hypertensionSatoko Arai, Kazuhiro Kurasawa, Reika Maezawa, et al.
Modern Rheumatology|May 22, 2010
Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosusKazuhiro Kurasawa, Satoko Arai, Takayoshi Owada, et al.
Oxford Medical Case Reports|July 24, 2023
Pneumatosis intestinalis in a patient with anti-synthetase syndromeTomoka Hiyama, Anna Hasegawa, Sara Komatsu, et al.
Modern Rheumatology|January 7, 2014
Peripheral nervous system involvement complicated due to vasculitis in cases of primary Sjögren's syndrome: case studies in a single hospital and a literature reviewYusuke Miwa, Shigeko Inokuma, Yoshimi Yokoe, et al.
Modern Rheumatology|April 3, 2012
Positivity for anti-RNP antibody is a risk factor for adverse effects caused by trimethoprim-sulfamethoxazole, a prophylactic agent for P. jiroveci pneumonia, in patients with connective tissue diseasesReika Maezawa, Kazuhiro Kurasawa, Satoko Arai, et al.
Modern Rheumatology|September 15, 2011
Reactivation of cytomegalovirus predicts poor prognosis in patients on intensive immunosuppressive treatment for collagen-vascular diseasesRyosuke Hanaoka, Kazuhiro Kurasawa, Reika Maezawa, et al.
The Journal of Rheumatology|July 4, 2012
Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositisTakayoshi Owada, Reika Maezawa, Kazuhiro Kurasawa, et al.
Modern Rheumatology|September 18, 2012
Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositisSatoko Arai, Kazuhiro Kurasawa, Reika Maezawa, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Rheumatic Diseases|November 1, 2023
Subclinical myositis in antisynthetase syndrome-Does it matter?Kei Ikeda, Reika Maezawa, Kazuhiro Kurasawa
The Journal of Rheumatology|February 13, 2013
Dr. Owada, et al, replyTakayoshi Owada, Reika Maezawa, Kazuhiro Kurasawa
Modern Rheumatology|June 28, 2011
Systemic sclerosis complicated by arrhythmogenic right ventricular dysplasia that was misinterpreted as pulmonary arterial hypertensionSatoko Arai, Kazuhiro Kurasawa, Reika Maezawa, et al.
Modern Rheumatology|May 22, 2010
Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosusKazuhiro Kurasawa, Satoko Arai, Takayoshi Owada, et al.
Oxford Medical Case Reports|July 24, 2023
Pneumatosis intestinalis in a patient with anti-synthetase syndromeTomoka Hiyama, Anna Hasegawa, Sara Komatsu, et al.
Modern Rheumatology|January 7, 2014
Peripheral nervous system involvement complicated due to vasculitis in cases of primary Sjögren's syndrome: case studies in a single hospital and a literature reviewYusuke Miwa, Shigeko Inokuma, Yoshimi Yokoe, et al.
Modern Rheumatology|April 3, 2012
Positivity for anti-RNP antibody is a risk factor for adverse effects caused by trimethoprim-sulfamethoxazole, a prophylactic agent for P. jiroveci pneumonia, in patients with connective tissue diseasesReika Maezawa, Kazuhiro Kurasawa, Satoko Arai, et al.
Modern Rheumatology|September 15, 2011
Reactivation of cytomegalovirus predicts poor prognosis in patients on intensive immunosuppressive treatment for collagen-vascular diseasesRyosuke Hanaoka, Kazuhiro Kurasawa, Reika Maezawa, et al.
The Journal of Rheumatology|July 4, 2012
Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositisTakayoshi Owada, Reika Maezawa, Kazuhiro Kurasawa, et al.
Modern Rheumatology|September 18, 2012
Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositisSatoko Arai, Kazuhiro Kurasawa, Reika Maezawa, et al.
Pageof 3